previous
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents:a secondary analysis of the ODYSSEY trial
next
Risk of adverse birth outcomes and birth defects among women living with HIV on antiretroviral therapy and HIV-negative women in Uganda, 2015–2021
© 2022 MU-JHU Research Collaboration. All rights reserved